TY - JOUR T1 - Clinical pharmacist intervention in Appendectomy - Dexmedetomidine as an adjunct therapy A1 - Bushra Abdel-Hadi A1 - Sami Raid Abdel-Fattah JF - Journal of Advanced Pharmacy Education and Research JO - J Adv Pharm Educ Res SN - 2249-3379 Y1 - 2022 VL - 12 IS - 2 DO - 10.51847/AYOZXtLMrj SP - 1 EP - 5 N2 - This research was performed by a clinical pharmacist to determine the efficacy of dexmedetomidine as an alternative therapy in laparoscopic appendectomy surgery for acute and short-lived analgesic appendicitis and to focus on the consistency of pharmacotherapy and patient safety. A randomized, double-blind, prospective analysis of 2 groups allocated to the fentanyl [GF] and fentanyl dexmedetomidine [GF-D] groups. Propofol, Sevoflurane, Atracurium, and intraoperative fentanyl bolus were administered to the patient, followed by an infusion of maintenance dose of 0.2 μg/kg/h for the two grades. GF patients were given placebo, however, while patients with GF-D received both dexmedetomidine and fentanyl as an infusion (0.5 μg/kg/h). The requirements for postoperative analgesics and the need for initial postoperative analgesics, consistency of hemodynamic parameters, side effects of nausea and vomiting, and food tolerance have been controlled. GF-D showed lower side effects and food resistance compared to GF: pain score, morphine consumption, nausea, and vomiting (p UR - https://japer.in/article/clinical-pharmacist-intervention-in-appendectomy-dexmedetomidine-as-an-adjunct-therapy-pahuqc3lhnemsfi ER -